Vir Biotechnology, Inc. (VIR)
USD 5.58
(-6.38%)
USD 5.58
(-6.38%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 369.85 Million USD | -48.92% |
| 2022 | 724.12 Million USD | 38.61% |
| 2021 | 522.41 Million USD | 158.74% |
| 2020 | 201.9 Million USD | 129.11% |
| 2019 | 88.12 Million USD | -76.23% |
| 2018 | 370.77 Million USD | 15.69% |
| 2017 | 320.48 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 235.88 Million USD | -4.35% |
| 2024 Q3 | 257.62 Million USD | 9.22% |
| 2024 Q1 | 246.61 Million USD | -33.32% |
| 2023 FY | 369.85 Million USD | -48.92% |
| 2023 Q3 | 369.81 Million USD | -14.72% |
| 2023 Q4 | 369.85 Million USD | 0.01% |
| 2023 Q1 | 695.13 Million USD | -4.0% |
| 2023 Q2 | 433.66 Million USD | -37.61% |
| 2022 Q3 | 546.11 Million USD | -18.12% |
| 2022 Q4 | 724.12 Million USD | 32.6% |
| 2022 FY | 724.12 Million USD | 38.61% |
| 2022 Q1 | 886.11 Million USD | 69.62% |
| 2022 Q2 | 666.98 Million USD | -24.73% |
| 2021 Q1 | 484.63 Million USD | 140.03% |
| 2021 Q4 | 522.41 Million USD | 56.44% |
| 2021 FY | 522.41 Million USD | 158.74% |
| 2021 Q3 | 333.93 Million USD | 4.27% |
| 2021 Q2 | 320.25 Million USD | -33.92% |
| 2020 FY | 201.9 Million USD | 129.11% |
| 2020 Q4 | 201.9 Million USD | 54.24% |
| 2020 Q3 | 130.9 Million USD | 20.69% |
| 2020 Q2 | 108.45 Million USD | 12.07% |
| 2020 Q1 | 96.78 Million USD | 9.82% |
| 2019 Q1 | - USD | -100.0% |
| 2019 FY | 88.12 Million USD | -76.23% |
| 2019 Q2 | 55.39 Million USD | 0.0% |
| 2019 Q4 | 88.12 Million USD | -87.47% |
| 2019 Q3 | 703.43 Million USD | 1169.84% |
| 2018 Q4 | 370.77 Million USD | 0.0% |
| 2018 Q1 | - USD | 0.0% |
| 2018 FY | 370.77 Million USD | 15.69% |
| 2017 FY | 320.48 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| AbCellera Biologics Inc. | 335.77 Million USD | -10.149% |
| Alkermes plc | 933.53 Million USD | 60.381% |
| Agenus Inc. | 462.29 Million USD | 19.996% |
| Alnylam Pharmaceuticals, Inc. | 4.05 Billion USD | 90.869% |
| Aptorum Group Limited | 5.25 Million USD | -6935.808% |
| Ardelyx, Inc. | 130.76 Million USD | -182.843% |
| Arrowhead Pharmaceuticals, Inc. | 478.39 Million USD | 22.688% |
| Bicycle Therapeutics plc | 224.41 Million USD | -64.81% |
| BioXcel Therapeutics, Inc. | 130.21 Million USD | -184.044% |
| ChromaDex Corporation | 26.5 Million USD | -1295.254% |
| Chimerix, Inc. | 19.74 Million USD | -1773.153% |
| Corbus Pharmaceuticals Holdings, Inc. | 35.17 Million USD | -951.405% |
| Caribou Biosciences, Inc. | 72.56 Million USD | -409.672% |
| CRISPR Therapeutics AG | 346.76 Million USD | -6.657% |
| Precision BioSciences, Inc. | 140.92 Million USD | -162.457% |
| Dyadic International, Inc. | 2.34 Million USD | -15701.33% |
| Eton Pharmaceuticals, Inc. | 16.26 Million USD | -2174.205% |
| Fortress Biotech, Inc. | 165.93 Million USD | -122.886% |
| Lantern Pharma Inc. | 2.73 Million USD | -13399.888% |
| HOOKIPA Pharma Inc. | 71.48 Million USD | -417.423% |
| Inhibikase Therapeutics, Inc. | 3.52 Million USD | -10381.236% |
| Incyte Corporation | 1.59 Billion USD | 76.772% |
| IO Biotech, Inc. | 17.55 Million USD | -2006.71% |
| Jaguar Health, Inc. | 45.86 Million USD | -706.379% |
| Novavax, Inc. | 2.57 Billion USD | 85.621% |
| Janux Therapeutics, Inc. | 36.05 Million USD | -925.72% |
| Opthea Limited | 264.6 Million USD | -39.778% |
| Ligand Pharmaceuticals Incorporated | 130.7 Million USD | -182.964% |
| ContextLogic Inc. | 206 Million USD | -79.541% |
| MiMedx Group, Inc. | 96.33 Million USD | -283.945% |
| Pyxis Oncology, Inc. | 48.02 Million USD | -670.176% |
| TransCode Therapeutics, Inc. | 3.52 Million USD | -10380.755% |
| NextCure, Inc. | 14.99 Million USD | -2366.187% |
| Ocuphire Pharma, Inc. | 4.04 Million USD | -9050.272% |
| Oncternal Therapeutics, Inc. | 6.67 Million USD | -5439.224% |
| Outlook Therapeutics, Inc. | 46.73 Million USD | -691.318% |
| Vaxcyte, Inc. | 167.44 Million USD | -120.876% |
| PDS Biotechnology Corporation | 33.25 Million USD | -1012.037% |
| Madrigal Pharmaceuticals, Inc. | 235.21 Million USD | -57.241% |
| Pharming Group N.V. | 244.07 Million USD | -51.534% |
| Pieris Pharmaceuticals, Inc. | 11.92 Million USD | -3002.281% |
| Avidity Biosciences, Inc. | 127.79 Million USD | -189.421% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -5497.675% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -5497.675% |
| Sangamo Therapeutics, Inc. | 82.43 Million USD | -348.672% |
| Sol-Gel Technologies Ltd. | 6.64 Million USD | -5467.575% |
| Acelyrin, Inc. | 86.35 Million USD | -328.305% |
| Salarius Pharmaceuticals, Inc. | 1.29 Million USD | -28366.928% |
| SELLAS Life Sciences Group, Inc. | 14.37 Million USD | -2472.182% |
| Summit Therapeutics Inc. | 125.25 Million USD | -195.276% |
| Sensei Biotherapeutics, Inc. | 9.47 Million USD | -3801.825% |
| Senti Biosciences, Inc. | 52.57 Million USD | -603.532% |
| Stoke Therapeutics, Inc. | 68.77 Million USD | -437.758% |
| Syros Pharmaceuticals, Inc. | 151.51 Million USD | -144.109% |
| Alaunos Therapeutics, Inc. | 1.95 Million USD | -18808.691% |
| Telomir Pharmaceuticals, Inc. Common Stock | 1.33 Million USD | -27592.72% |
| Entrada Therapeutics, Inc. | 226.83 Million USD | -63.052% |
| VistaGen Therapeutics, Inc. | 9.36 Million USD | -3848.479% |
| Wave Life Sciences Ltd. | 227.44 Million USD | -62.612% |
| Sorrento Therapeutics, Inc. | 494.5 Million USD | 25.208% |
| TRACON Pharmaceuticals, Inc. | 10.91 Million USD | -3288.803% |
| Barinthus Biotherapeutics plc | 27.51 Million USD | -1244.386% |
| Psyence Biomedical Ltd. | 12.1 Million USD | -2955.458% |
| Phathom Pharmaceuticals, Inc. | 486.6 Million USD | 23.992% |
| Immix Biopharma, Inc. | 3.72 Million USD | -9837.549% |
| Keros Therapeutics, Inc. | 37.81 Million USD | -878.139% |
| MEI Pharma, Inc. | 8.35 Million USD | -4326.738% |
| Windtree Therapeutics, Inc. | 29.01 Million USD | -1174.699% |
| Xeris Biopharma Holdings, Inc. | 347.58 Million USD | -6.408% |
| Rigel Pharmaceuticals, Inc. | 145.86 Million USD | -153.552% |
| Fortress Biotech, Inc. | 165.93 Million USD | -122.886% |
| Precigen, Inc. | 41.64 Million USD | -788.133% |
| Clearside Biomedical, Inc. | 49.93 Million USD | -640.745% |
| AlloVir, Inc. | 45.01 Million USD | -721.624% |
| C4 Therapeutics, Inc. | 130.33 Million USD | -183.767% |
| Fate Therapeutics, Inc. | 137.8 Million USD | -168.399% |
| ImmuCell Corporation | 18.81 Million USD | -1865.737% |
| IDEAYA Biosciences, Inc. | 28.22 Million USD | -1210.331% |
| Onconetix, Inc. | 23.18 Million USD | -1495.513% |
| PureTech Health plc | 125.58 Million USD | -194.51% |
| VYNE Therapeutics Inc. | 8.95 Million USD | -4032.447% |
| Elevation Oncology, Inc. | 34.28 Million USD | -978.858% |
| Kintara Therapeutics, Inc. | 2.44 Million USD | -15026.953% |
| Seer, Inc. | 39.36 Million USD | -839.55% |
| Verrica Pharmaceuticals Inc. | 61.83 Million USD | -498.14% |
| Innoviva, Inc. | 568.55 Million USD | 34.948% |
| Aadi Bioscience, Inc. | 27.22 Million USD | -1258.359% |
| ESSA Pharma Inc. | 3.49 Million USD | -10482.16% |
| GlycoMimetics, Inc. | 6.9 Million USD | -5258.592% |
| GT Biopharma, Inc. | 6.63 Million USD | -5475.969% |
| Inhibrx Biosciences, Inc. | 264.39 Million USD | -39.89% |
| Akebia Therapeutics, Inc. | 272.28 Million USD | -35.832% |
| Catalyst Pharmaceuticals, Inc. | 84.02 Million USD | -340.166% |
| Longboard Pharmaceuticals, Inc. | 9.77 Million USD | -3684.06% |
| Orchestra BioMed Holdings, Inc. | 27.16 Million USD | -1261.309% |
| Alzamend Neuro, Inc. | 3.22 Million USD | -11365.593% |
| Rocket Pharmaceuticals, Inc. | 73.76 Million USD | -401.381% |
| Aptose Biosciences Inc. | 15.8 Million USD | -2239.56% |
| ZyVersa Therapeutics, Inc. | 11.03 Million USD | -3250.222% |
| Soligenix, Inc. | 7.27 Million USD | -4983.971% |
| Century Therapeutics, Inc. | 175.94 Million USD | -110.215% |
| Kura Oncology, Inc. | 51.66 Million USD | -615.911% |
| TScan Therapeutics, Inc. | 121.28 Million USD | -204.954% |
| Intensity Therapeutics, Inc. | 4.13 Million USD | -8848.802% |
| Ocean Biomedical, Inc. | 6.61 Million USD | -5492.109% |
| CytomX Therapeutics, Inc. | 252.59 Million USD | -46.42% |
| Autolus Therapeutics plc | 263.9 Million USD | -40.146% |
| Mineralys Therapeutics, Inc. | 10.48 Million USD | -3428.468% |
| EyePoint Pharmaceuticals, Inc. | 88.86 Million USD | -316.216% |
| Eterna Therapeutics Inc. | 46.89 Million USD | -688.618% |
| Adaptive Biotechnologies Corporation | 352.85 Million USD | -4.817% |
| GRI Bio, Inc. | 2.69 Million USD | -13613.534% |
| Xenetic Biosciences, Inc. | 809.58 Thousand USD | -45584.394% |
| Tenaya Therapeutics, Inc. | 31.09 Million USD | -1089.585% |
| IGM Biosciences, Inc. | 220.17 Million USD | -67.98% |
| INmune Bio, Inc. | 18.86 Million USD | -1860.842% |
| Heron Therapeutics, Inc. | 256.47 Million USD | -44.204% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -1288.246% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -13505.547% |
| Entero Therapeutics, Inc. | 3.28 Million USD | -11175.122% |
| Milestone Pharmaceuticals Inc. | 58.45 Million USD | -532.716% |
| X4 Pharmaceuticals, Inc. | 96.15 Million USD | -284.628% |
| Atara Biotherapeutics, Inc. | 264.73 Million USD | -39.707% |
| Coherus BioSciences, Inc. | 823.02 Million USD | 55.062% |
| Verastem, Inc. | 71.18 Million USD | -419.567% |
| Abeona Therapeutics Inc. | 49.17 Million USD | -652.103% |
| Pliant Therapeutics, Inc. | 38.57 Million USD | -858.717% |
| Tonix Pharmaceuticals Holding Corp. | 48.93 Million USD | -655.853% |
| Histogen Inc. | 5.69 Million USD | -6392.084% |
| Aprea Therapeutics, Inc. | 4.38 Million USD | -8333.363% |
| Surrozen, Inc. | 8.14 Million USD | -4440.872% |
| Organovo Holdings, Inc. | 2.74 Million USD | -13359.025% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -117741.189% |
| Ovid Therapeutics Inc. | 56.22 Million USD | -557.753% |
| Panbela Therapeutics, Inc. | 16.51 Million USD | -2139.91% |
| CASI Pharmaceuticals, Inc. | 51.1 Million USD | -623.742% |
| Cadrenal Therapeutics, Inc. Common Stock | 826.87 Thousand USD | -44629.131% |
| Centessa Pharmaceuticals plc | 126.72 Million USD | -191.856% |
| Hepion Pharmaceuticals, Inc. | 10.81 Million USD | -3320.27% |
| Arcturus Therapeutics Holdings Inc. | 150.88 Million USD | -145.117% |
| BioRestorative Therapies, Inc. | 2.6 Million USD | -14085.081% |
| Apollomics, Inc. | 14.15 Million USD | -2513.255% |
| Amarin Corporation plc | 279.58 Million USD | -32.286% |
| Mesoblast Limited | 188.79 Million USD | -95.899% |
| Turnstone Biologics Corp. | 14.14 Million USD | -2514.179% |
| Kymera Therapeutics, Inc. | 180.78 Million USD | -104.579% |
| Synaptogenix, Inc. | 5.52 Million USD | -6588.78% |
| Tiziana Life Sciences Ltd | 6.64 Million USD | -5463.387% |
| Aurinia Pharmaceuticals Inc. | 170.1 Million USD | -117.423% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -4222.142% |
| Monopar Therapeutics Inc. | 1.75 Million USD | -20945.606% |
| Exelixis, Inc. | 678.44 Million USD | 45.485% |
| Better Therapeutics, Inc. | 23.84 Million USD | -1451.271% |
| Nurix Therapeutics, Inc. | 164.04 Million USD | -125.457% |
| Apellis Pharmaceuticals, Inc. | 594.2 Million USD | 37.757% |
| NLS Pharmaceutics AG | 10.68 Million USD | -3362.986% |
| Dermata Therapeutics, Inc. | 1.62 Million USD | -22679.647% |
| Aridis Pharmaceuticals, Inc. | 38.92 Million USD | -850.122% |
| Gritstone bio, Inc. | 125.91 Million USD | -193.724% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -2420.128% |
| TNF Pharmaceuticals, Inc. | 5.08 Million USD | -7168.247% |
| Avid Bioservices, Inc. | 275.66 Million USD | -34.166% |
| Insmed Incorporated | 1.66 Billion USD | 77.743% |
| Virpax Pharmaceuticals, Inc. | 7.69 Million USD | -4707.029% |
| MediWound Ltd. | 27.18 Million USD | -1260.408% |
| OmniAb, Inc. | 87.4 Million USD | -323.174% |
| Alector, Inc. | 487.66 Million USD | 24.159% |
| Seres Therapeutics, Inc. | 403.45 Million USD | 8.329% |
| Checkpoint Therapeutics, Inc. | 18.42 Million USD | -1907.349% |
| Viracta Therapeutics, Inc. | 38.37 Million USD | -863.839% |
| Zai Lab Limited | 240.17 Million USD | -53.992% |
| Revance Therapeutics, Inc. | 630.05 Million USD | 41.298% |
| Aura Biosciences, Inc. | 29.22 Million USD | -1165.453% |
| Lyell Immunopharma, Inc. | 95.07 Million USD | -289.005% |
| Immunic, Inc. | 25.36 Million USD | -1357.955% |
| Tarsus Pharmaceuticals, Inc. | 69.23 Million USD | -434.193% |
| Veracyte, Inc. | 93.71 Million USD | -294.641% |
| InMed Pharmaceuticals Inc. | 2.61 Million USD | -14034.514% |
| FibroGen, Inc. | 585.72 Million USD | 36.856% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -2027.676% |
| Adial Pharmaceuticals, Inc. | 653.07 Thousand USD | -56532.612% |
| Sonnet BioTherapeutics Holdings, Inc. | 5.65 Million USD | -6439.771% |
| Jazz Pharmaceuticals plc | 7.65 Billion USD | 95.169% |
| Cyclacel Pharmaceuticals, Inc. | 8.19 Million USD | -4411.515% |
| Amylyx Pharmaceuticals, Inc. | 84.02 Million USD | -340.187% |
| TG Therapeutics, Inc. | 169.08 Million USD | -118.739% |
| Galecto, Inc. | 5.89 Million USD | -6172.965% |
| Calithera Biosciences, Inc. | 8.28 Million USD | -4364.679% |
| Fortrea Holdings Inc. | 2.61 Billion USD | 85.875% |
| KalVista Pharmaceuticals, Inc. | 28.82 Million USD | -1183.235% |
| Aptevo Therapeutics Inc. | 12.62 Million USD | -2830.465% |
| XBiotech Inc. | 8.39 Million USD | -4304.597% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -2420.128% |
| Lyra Therapeutics, Inc. | 53.18 Million USD | -595.476% |
| Foghorn Therapeutics Inc. | 363.1 Million USD | -1.858% |
| Y-mAbs Therapeutics, Inc. | 26.88 Million USD | -1275.74% |
| Theravance Biopharma, Inc. | 169 Million USD | -118.843% |
| Ultragenyx Pharmaceutical Inc. | 1.21 Billion USD | 69.574% |
| Metagenomi, Inc. Common Stock | 500.42 Million USD | 26.092% |
| Vaxxinity, Inc. | 30.94 Million USD | -1095.237% |
| BioCryst Pharmaceuticals, Inc. | 972.48 Million USD | 61.968% |
| Gain Therapeutics, Inc. | 6.03 Million USD | -6032.44% |
| Cartesian Therapeutics, Inc. | 745.23 Million USD | 50.371% |
| NexImmune, Inc. | 5.08 Million USD | -7174.53% |
| Creative Medical Technology Holdings, Inc. | 371.39 Thousand USD | -99485.346% |
| Marker Therapeutics, Inc. | 3.07 Million USD | -11928.367% |
| Regeneron Pharmaceuticals, Inc. | 7.1 Billion USD | 94.796% |
| Chemomab Therapeutics Ltd. | 5.15 Million USD | -7076.016% |
| Scopus BioPharma Inc. | 7.45 Million USD | -4861.53% |
| RAPT Therapeutics, Inc. | 26.29 Million USD | -1306.61% |
| Ainos, Inc. | 7.39 Million USD | -4901.932% |
| Pluri Inc. | 34.11 Million USD | -984.234% |
| Prothena Corporation plc | 135.01 Million USD | -173.931% |
| Adaptimmune Therapeutics plc | 243.1 Million USD | -52.139% |
| Celularity Inc. | 102.92 Million USD | -259.329% |
| Rallybio Corporation | 9.43 Million USD | -3819.606% |
| Cue Biopharma, Inc. | 24.44 Million USD | -1413.005% |
| MeiraGTx Holdings plc | 319.99 Million USD | -15.583% |
| Omeros Corporation | 403.25 Million USD | 8.282% |
| Humacyte, Inc. | 114.67 Million USD | -222.518% |
| Immunocore Holdings plc | 228.15 Million USD | -62.104% |
| Cocrystal Pharma, Inc. | 4.87 Million USD | -7486.749% |
| Cidara Therapeutics, Inc. | 76.74 Million USD | -381.957% |
| Blueprint Medicines Corporation | 918.64 Million USD | 59.739% |
| CalciMedica, Inc. | 4.02 Million USD | -9082.075% |
| Cabaletta Bio, Inc. | 17.45 Million USD | -2019.264% |
| Marinus Pharmaceuticals, Inc. | 154.14 Million USD | -139.942% |
| Scholar Rock Holding Corporation | 85.81 Million USD | -330.98% |
| Sana Biotechnology, Inc. | 277.79 Million USD | -33.14% |
| Pulmatrix, Inc. | 15.96 Million USD | -2216.945% |
| Elicio Therapeutics, Inc. | 15.77 Million USD | -2244.855% |
| Vigil Neuroscience, Inc. | 24.6 Million USD | -1403.105% |
| Intellia Therapeutics, Inc. | 250.8 Million USD | -47.465% |
| Adlai Nortye Ltd. American Depositary Shares | 50.78 Million USD | -628.26% |
| Cytokinetics, Incorporated | 1.21 Billion USD | 69.45% |
| Eloxx Pharmaceuticals, Inc. | 31.78 Million USD | -1063.685% |
| Nutriband Inc. | 1.07 Million USD | -34180.053% |
| Protara Therapeutics, Inc. | 10.63 Million USD | -3378.36% |
| Vor Biopharma Inc. | 59.1 Million USD | -525.768% |
| Roivant Sciences Ltd. | 773.95 Million USD | 52.212% |
| Evogene Ltd. | 17.99 Million USD | -1955.887% |
| ProKidney Corp. | 29.21 Million USD | -1165.93% |
| Applied Therapeutics, Inc. | 71.97 Million USD | -413.836% |
| Hoth Therapeutics, Inc. | 704.98 Thousand USD | -52362.825% |
| BridgeBio Pharma, Inc. | 1.88 Billion USD | 80.42% |
| CorMedix Inc. | 11.91 Million USD | -3003.446% |
| BioLineRx Ltd. | 50.7 Million USD | -629.466% |
| Tango Therapeutics, Inc. | 149.45 Million USD | -147.462% |
| Galectin Therapeutics Inc. | 88.44 Million USD | -318.193% |
| Atai Life Sciences N.V. | 49.16 Million USD | -652.317% |
| Renovaro Biosciences Inc. | 31.15 Million USD | -1087.244% |
| Aerovate Therapeutics, Inc. | 17.96 Million USD | -1959.091% |
| Zentalis Pharmaceuticals, Inc. | 124.63 Million USD | -196.747% |
| Sagimet Biosciences Inc. | 5.65 Million USD | -6441.457% |
| MediciNova, Inc. | 3.89 Million USD | -9404.021% |
| Praxis Precision Medicines, Inc. | 18.27 Million USD | -1923.382% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -24487.417% |
| GeoVax Labs, Inc. | 3.51 Million USD | -10407.571% |
| Axsome Therapeutics, Inc. | 397.25 Million USD | 6.899% |
| Biomea Fusion, Inc. | 30.69 Million USD | -1105.129% |
| PTC Therapeutics, Inc. | 2.72 Billion USD | 86.411% |
| Mereo BioPharma Group plc | 15.96 Million USD | -2217.091% |
| Cullinan Oncology, Inc. | 31.2 Million USD | -1085.391% |
| Syndax Pharmaceuticals, Inc. | 58.68 Million USD | -530.247% |
| Absci Corporation | 58.3 Million USD | -534.354% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -1841.695% |
| 4D Molecular Therapeutics, Inc. | 32.06 Million USD | -1053.559% |
| Dyne Therapeutics, Inc. | 73.79 Million USD | -401.225% |
| Kiniksa Pharmaceuticals, Ltd. | 87.48 Million USD | -322.772% |
| Ventyx Biosciences, Inc. | 33.77 Million USD | -995.215% |
| Allakos Inc. | 74.79 Million USD | -394.503% |
| Imunon, Inc. | 8.53 Million USD | -4235.703% |
| Fulcrum Therapeutics, Inc. | 22.5 Million USD | -1543.723% |
| Corcept Therapeutics Incorporated | 114.81 Million USD | -222.139% |
| BioAtla, Inc. | 48.98 Million USD | -655.02% |
| NLS Pharmaceutics AG | 10.68 Million USD | -3362.986% |
| Bio-Path Holdings, Inc. | 2.77 Million USD | -13208.888% |
| Allogene Therapeutics, Inc. | 130.6 Million USD | -183.187% |
| Larimar Therapeutics, Inc. | 14.21 Million USD | -2501.857% |
| XOMA Corporation | 145.58 Million USD | -154.056% |
| Kezar Life Sciences, Inc. | 33.66 Million USD | -998.631% |
| Cara Therapeutics, Inc. | 68.75 Million USD | -437.899% |
| aTyr Pharma, Inc. | 31.59 Million USD | -1070.535% |
| Aligos Therapeutics, Inc. | 61.82 Million USD | -498.247% |
| Akero Therapeutics, Inc. | 44.96 Million USD | -722.538% |
| Viridian Therapeutics, Inc. | 48.4 Million USD | -664.13% |
| Eliem Therapeutics, Inc. | 2.87 Million USD | -12786.899% |
| EyeGate Pharmaceuticals, Inc. | 8.15 Million USD | -4433.626% |
| Akari Therapeutics, Plc | 4.58 Million USD | -7968.368% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -1985.667% |
| Halozyme Therapeutics, Inc. | 1.64 Billion USD | 77.577% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -91468.872% |
| UroGen Pharma Ltd. | 243.52 Million USD | -51.876% |
| Sutro Biopharma, Inc. | 321.08 Million USD | -15.188% |
| ZIVO Bioscience, Inc. | 2.76 Million USD | -13292.947% |
| Orgenesis Inc. | 35.53 Million USD | -940.816% |
| Entera Bio Ltd. | 1.37 Million USD | -26720.45% |
| GH Research PLC | 6.7 Million USD | -5419.385% |
| Lisata Therapeutics, Inc. | 6.8 Million USD | -5339.029% |
| Reneo Pharmaceuticals, Inc. | 18.82 Million USD | -1864.592% |
| Xencor, Inc. | 283.55 Million USD | -30.433% |
| 60 Degrees Pharmaceuticals, Inc. | 2.98 Million USD | -12287.618% |
| Replimune Group, Inc. | 113.21 Million USD | -226.686% |
| Coeptis Therapeutics Holdings, Inc. | 3.75 Million USD | -9744.07% |
| Vanda Pharmaceuticals Inc. | 103.53 Million USD | -257.243% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -91468.872% |
| Portage Biotech Inc. | 4.45 Million USD | -8211.326% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -24487.417% |
| Olema Pharmaceuticals, Inc. | 23.05 Million USD | -1504.573% |
| OncoCyte Corporation | 49.29 Million USD | -650.241% |
| Qualigen Therapeutics, Inc. | 4.13 Million USD | -8840.571% |
| Processa Pharmaceuticals, Inc. | 797.48 Thousand USD | -46277.608% |
| Purple Biotech Ltd. | 10 Million USD | -3596.692% |
| CollPlant Biotechnologies Ltd. | 5.78 Million USD | -6292.223% |
| scPharmaceuticals Inc. | 57.26 Million USD | -545.909% |
| ProMIS Neurosciences, Inc. | 12.38 Million USD | -2885.578% |
| HilleVax, Inc. | 78.9 Million USD | -368.71% |
| NeuroSense Therapeutics Ltd. | 5.05 Million USD | -7223.842% |
| Tharimmune, Inc. | 1.81 Million USD | -20277.114% |
| Genprex, Inc. | 3.25 Million USD | -11265.407% |
| Neumora Therapeutics, Inc. Common Stock | 27.11 Million USD | -1263.819% |
| Atossa Therapeutics, Inc. | 5.23 Million USD | -6963.675% |
| XTL Biopharmaceuticals Ltd. | 206 Thousand USD | -179440.777% |
| Virios Therapeutics, Inc. | 358.54 Thousand USD | -103053.274% |
| OKYO Pharma Limited | 7.42 Million USD | -4883.987% |
| Savara Inc. | 37.19 Million USD | -894.445% |
| Curis, Inc. | 57.61 Million USD | -541.974% |
| Daré Bioscience, Inc. | 26.32 Million USD | -1304.694% |
| Carmell Therapeutics Corporation | 39.19 Million USD | -843.51% |
| Titan Pharmaceuticals, Inc. | 1.44 Million USD | -25513.158% |
| Achieve Life Sciences, Inc. | 20.81 Million USD | -1676.521% |
| BeiGene, Ltd. | 2.23 Billion USD | 83.442% |
| Kiromic BioPharma, Inc. | 21.28 Million USD | -1637.236% |
| Revolution Medicines, Inc. Warrant | 262.39 Million USD | -40.952% |
| Protagonist Therapeutics, Inc. | 21.27 Million USD | -1638.526% |
| Erasca, Inc. | 78.61 Million USD | -370.486% |
| bluebird bio, Inc. | 424.62 Million USD | 12.898% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -56344.543% |
| BioMarin Pharmaceutical Inc. | 1.89 Billion USD | 80.432% |
| DBV Technologies S.A. | 42.8 Million USD | -764.145% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -56344.543% |
| Moderna, Inc. | 4.57 Billion USD | 91.91% |
| Vincerx Pharma, Inc. | 6.99 Million USD | -5187.405% |
| Fresh Tracks Therapeutics, Inc. | 1.65 Million USD | -22234.179% |
| Molecular Templates, Inc. | 31.17 Million USD | -1086.532% |
| Acrivon Therapeutics, Inc. Common Stock | 17.07 Million USD | -2066.69% |
| Travere Therapeutics, Inc. | 588.1 Million USD | 37.111% |
| Monte Rosa Therapeutics, Inc. | 124.5 Million USD | -197.06% |
| Spruce Biosciences, Inc. | 27.43 Million USD | -1248.012% |
| Celldex Therapeutics, Inc. | 36.45 Million USD | -914.522% |
| Cogent Biosciences, Inc. | 55.63 Million USD | -564.787% |
| MacroGenics, Inc. | 154.2 Million USD | -139.843% |
| RenovoRx, Inc. | 4.46 Million USD | -8181.549% |
| Adicet Bio, Inc. | 37.12 Million USD | -896.374% |
| Prime Medicine, Inc. | 60.78 Million USD | -508.513% |
| Aditxt, Inc. | 28.53 Million USD | -1196.298% |
| Adagene Inc. | 45.16 Million USD | -718.816% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -204577.34% |
| Quantum-Si incorporated | 26.63 Million USD | -1288.81% |
| Maravai LifeSciences Holdings, Inc. | 697.56 Million USD | 46.979% |
| Acurx Pharmaceuticals, Inc. | 3.04 Million USD | -12056.501% |
| Voyager Therapeutics, Inc. | 114.96 Million USD | -221.721% |
| SciSparc Ltd. | 1.59 Million USD | -23088.339% |
| Vericel Corporation | 127.7 Million USD | -189.616% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -6546.2% |
| Minerva Neurosciences, Inc. | 85.35 Million USD | -333.297% |
| Generation Bio Co. | 171.63 Million USD | -115.495% |
| Astria Therapeutics, Inc. | 11.55 Million USD | -3102.199% |
| Black Diamond Therapeutics, Inc. | 41.83 Million USD | -784.162% |
| Arcutis Biotherapeutics, Inc. | 252.69 Million USD | -46.362% |
| Invivyd, Inc. | 51.71 Million USD | -615.205% |
| Relay Therapeutics, Inc. | 91.97 Million USD | -302.116% |
| Quoin Pharmaceuticals, Ltd. | 6.5 Million USD | -5585.469% |
| Spero Therapeutics, Inc. | 75.49 Million USD | -389.899% |
| Artelo Biosciences, Inc. | 1.02 Million USD | -36124.682% |
| 2seventy bio, Inc. | 310.12 Million USD | -19.259% |
| ADMA Biologics, Inc. | 193.97 Million USD | -90.67% |
| Clene Inc. | 38.95 Million USD | -849.537% |
| Capricor Therapeutics, Inc. | 36.13 Million USD | -923.595% |
| Boundless Bio, Inc. Common Stock | 256.97 Million USD | -43.926% |
| GeoVax Labs, Inc. | 3.51 Million USD | -10407.571% |
| Recursion Pharmaceuticals, Inc. | 190.26 Million USD | -94.391% |
| Citius Pharmaceuticals, Inc. | 12.17 Million USD | -2936.652% |
| Contineum Therapeutics, Inc. Class A Common Stock | 198.32 Million USD | -86.492% |
| Relmada Therapeutics, Inc. | 12.19 Million USD | -2932.883% |
| Finch Therapeutics Group, Inc. | 48.11 Million USD | -668.751% |
| ALX Oncology Holdings Inc. | 52.84 Million USD | -599.938% |
| Evaxion Biotech A/S | 17.61 Million USD | -1999.358% |
| Ocular Therapeutix, Inc. | 160.92 Million USD | -129.824% |
| Verve Therapeutics, Inc. | 153.18 Million USD | -141.441% |
| Trevena, Inc. | 48.26 Million USD | -666.346% |
| Surrozen, Inc. | 8.14 Million USD | -4440.872% |
| Tyra Biosciences, Inc. | 21.59 Million USD | -1612.683% |
| Cingulate Inc. | 10.36 Million USD | -3469.721% |
| Galmed Pharmaceuticals Ltd. | 2.75 Million USD | -13349.236% |
| Unity Biotechnology, Inc. | 37.29 Million USD | -891.778% |
| Tenax Therapeutics, Inc. | 3.58 Million USD | -10212.336% |
| Terns Pharmaceuticals, Inc. | 13.15 Million USD | -2712.578% |
| ACADIA Pharmaceuticals Inc. | 317.2 Million USD | -16.599% |
| Connect Biopharma Holdings Limited | 24.84 Million USD | -1388.406% |
| Clearmind Medicine Inc. | 3.61 Million USD | -10145.24% |
| Kronos Bio, Inc. | 54.2 Million USD | -582.375% |
| Bolt Biotherapeutics, Inc. | 47.04 Million USD | -686.204% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -1525.037% |
| Viking Therapeutics, Inc. | 20.07 Million USD | -1742.728% |
| Statera Biopharma, Inc. | 22.67 Million USD | -1531.005% |
| ImmunityBio, Inc. | 1.09 Billion USD | 66.081% |
| Korro Bio, Inc. | 51.75 Million USD | -614.666% |
| Kineta, Inc. | 7.22 Million USD | -5021.213% |
| BioVie Inc. | 9.7 Million USD | -3712.091% |
| Codexis, Inc. | 49.94 Million USD | -640.508% |
| Celularity Inc. | 102.92 Million USD | -259.329% |
| Crinetics Pharmaceuticals, Inc. | 96.24 Million USD | -284.276% |
| Celcuity Inc. | 51.45 Million USD | -618.86% |
| Virax Biolabs Group Limited | 345.19 Thousand USD | -107043.809% |
| Cibus, Inc. | 206.11 Million USD | -79.439% |
| Eledon Pharmaceuticals, Inc. | 42.47 Million USD | -770.757% |
| eFFECTOR Therapeutics, Inc. | 26.33 Million USD | -1304.207% |
| IN8bio, Inc. | 8.77 Million USD | -4116.302% |
| Kodiak Sciences Inc. | 213.59 Million USD | -73.16% |
| Annexon, Inc. | 47.11 Million USD | -684.953% |
| Adverum Biotechnologies, Inc. | 89.54 Million USD | -313.055% |
| Assembly Biosciences, Inc. | 96.37 Million USD | -283.777% |
| Avalo Therapeutics, Inc. | 13.68 Million USD | -2601.834% |
| Ionis Pharmaceuticals, Inc. | 2.6 Billion USD | 85.793% |
| Eyenovia, Inc. | 19.78 Million USD | -1769.812% |
| Puma Biotechnology, Inc. | 177.08 Million USD | -108.856% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -4715.18% |
| Xilio Therapeutics, Inc. | 24.09 Million USD | -1434.728% |
| Arcellx, Inc. | 339.75 Million USD | -8.86% |
| Cardiff Oncology, Inc. | 11.89 Million USD | -3008.539% |
| Enanta Pharmaceuticals, Inc. | 245.54 Million USD | -50.629% |
| Regulus Therapeutics Inc. | 9.56 Million USD | -3767.552% |
| Moolec Science SA | 13.94 Million USD | -2552.166% |
| Acumen Pharmaceuticals, Inc. | 43.15 Million USD | -757.096% |
| Geron Corporation | 146.12 Million USD | -153.104% |
| LAVA Therapeutics N.V. | 50.53 Million USD | -631.92% |
| Royalty Pharma plc | 6.29 Billion USD | 94.127% |
| Atea Pharmaceuticals, Inc. | 39.77 Million USD | -829.842% |
| Greenwich LifeSciences, Inc. | 294.4 Thousand USD | -125527.195% |
| TFF Pharmaceuticals, Inc. | 2.46 Million USD | -14932.992% |
| Mersana Therapeutics, Inc. | 189.15 Million USD | -95.529% |
| Humacyte, Inc. | 114.67 Million USD | -222.518% |
| Structure Therapeutics Inc. | 29.05 Million USD | -1173.119% |
| 89bio, Inc. | 59.96 Million USD | -516.804% |
| PMV Pharmaceuticals, Inc. | 26.46 Million USD | -1297.627% |
| Avenue Therapeutics, Inc. | 1.19 Million USD | -30824.247% |
| Genelux Corporation | 8.42 Million USD | -4292.565% |
| Trevi Therapeutics, Inc. | 6.85 Million USD | -5294.603% |
| Lexicon Pharmaceuticals, Inc. | 136.31 Million USD | -171.315% |
| Notable Labs, Ltd. | 4.42 Million USD | -8254.506% |
| Liquidia Corporation | 73.13 Million USD | -405.693% |
| Mustang Bio, Inc. | 17.61 Million USD | -1999.177% |
| Immunovant, Inc. | 48.95 Million USD | -655.498% |
| Quantum-Si incorporated | 26.63 Million USD | -1288.81% |
| Arbutus Biopharma Corporation | 38.38 Million USD | -863.588% |
| DiaMedica Therapeutics Inc. | 3.1 Million USD | -11819.239% |
| Vera Therapeutics, Inc. | 73.86 Million USD | -400.743% |
| Acasti Pharma Inc. | 11.55 Million USD | -3100.26% |
| MiNK Therapeutics, Inc. | 22.6 Million USD | -1535.963% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -13505.547% |
| Xenon Pharmaceuticals Inc. | 36.87 Million USD | -902.94% |
| Elevai Labs, Inc. Common Stock | 1.36 Million USD | -27038.436% |
| NeuroBo Pharmaceuticals, Inc. | 6.09 Million USD | -5967.159% |
| Tempest Therapeutics, Inc. | 24.83 Million USD | -1389.245% |
| Soleno Therapeutics, Inc. | 23.18 Million USD | -1495.298% |
| PepGen Inc. | 34.63 Million USD | -967.985% |
| Moleculin Biotech, Inc. | 12.14 Million USD | -2945.57% |
| United Therapeutics Corporation | 1.18 Billion USD | 68.715% |
| Nuvectis Pharma, Inc. | 6.98 Million USD | -5195.733% |
| Solid Biosciences Inc. | 38.45 Million USD | -861.709% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -4222.142% |
| Immuneering Corporation | 12 Million USD | -2979.972% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -117741.189% |
| Silo Pharma, Inc. | 1.56 Million USD | -23468.538% |
| Belite Bio, Inc | 4.21 Million USD | -8683.044% |
| XOMA Corporation | 145.58 Million USD | -154.056% |
| ARS Pharmaceuticals, Inc. | 2.42 Million USD | -15132.867% |
| Bionomics Limited | 10.15 Million USD | -3540.754% |
| Apogee Therapeutics, Inc. | 21.49 Million USD | -1620.972% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -1514.167% |
| uniQure N.V. | 624.01 Million USD | 40.73% |
| Cassava Sciences, Inc. | 14.19 Million USD | -2505.523% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -204577.34% |
| Poseida Therapeutics, Inc. | 170.18 Million USD | -117.326% |
| Forte Biosciences, Inc. | 3.66 Million USD | -9988.762% |
| Anebulo Pharmaceuticals, Inc. | 260.58 Thousand USD | -141833.28% |
| Enlivex Therapeutics Ltd. | 6.74 Million USD | -5381.755% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -4715.18% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -2027.676% |
| FibroBiologics, Inc. Common Stock | 10.56 Million USD | -3399.754% |
| Altimmune, Inc. | 16.54 Million USD | -2135.983% |
| Amicus Therapeutics, Inc. | 617.7 Million USD | 40.125% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -1514.167% |
| Compugen Ltd. | 55.77 Million USD | -563.118% |
| Peak Bio, Inc. | 20.75 Million USD | -1682.14% |
| Zevra Therapeutics, Inc. | 110.46 Million USD | -234.822% |
| Benitec Biopharma Inc. | 4.96 Million USD | -7353.728% |
| Spyre Therapeutics, Inc. | 157.84 Million USD | -134.318% |
| NKGen Biotech, Inc. Common Stock | 75.17 Million USD | -391.997% |
| Zura Bio Limited | 21.29 Million USD | -1637.056% |
| PolyPid Ltd. | 17.46 Million USD | -2017.323% |
| Aileron Therapeutics, Inc. | 112.39 Million USD | -229.055% |
| NKGen Biotech, Inc. Warrants | 75.17 Million USD | -391.997% |
| Instil Bio, Inc. | 99.8 Million USD | -270.591% |
| argenx SE | 444.95 Million USD | 16.878% |
| Immunome, Inc. | 28.65 Million USD | -1190.579% |
| Compass Therapeutics, Inc. | 8.33 Million USD | -4336.296% |
| Verona Pharma plc | 58.84 Million USD | -528.565% |
| enGene Holdings Inc. Warrants | 14.47 Million USD | -2455.476% |
| Shattuck Labs, Inc. | 14.85 Million USD | -2389.091% |
| CervoMed Inc. | 2.59 Million USD | -14148.461% |
| LENZ Therapeutics, Inc. | 4.87 Million USD | -7488.305% |
| Plus Therapeutics, Inc. | 12.73 Million USD | -2804.004% |
| Dianthus Therapeutics, Inc. | 10.53 Million USD | -3410.717% |
| Moolec Science SA | 13.94 Million USD | -2552.166% |
| Enveric Biosciences, Inc. | 2.34 Million USD | -15682.094% |
| Inovio Pharmaceuticals, Inc. | 55.59 Million USD | -565.261% |
| AnaptysBio, Inc. | 364.28 Million USD | -1.528% |
| Design Therapeutics, Inc. | 11.95 Million USD | -2993.459% |
| Leap Therapeutics, Inc. | 12.68 Million USD | -2815.91% |
| NeurAxis, Inc. | 1.91 Million USD | -19236.355% |
| Seelos Therapeutics, Inc. | 38.92 Million USD | -850.098% |
| Lumos Pharma, Inc. | 13.33 Million USD | -2673.974% |
| Achilles Therapeutics plc | 19.08 Million USD | -1837.727% |
| enGene Holdings Inc. Common Stock | 14.47 Million USD | -2455.476% |
| 180 Life Sciences Corp. | 5.38 Million USD | -6765.41% |
| Opiant Pharmaceuticals, Inc. | 23.58 Million USD | -1467.976% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -1525.037% |
| Nutriband Inc. | 1.07 Million USD | -34180.053% |
| ORIC Pharmaceuticals, Inc. | 30.59 Million USD | -1108.752% |
| CG Oncology, Inc. Common stock | 14.51 Million USD | -2448.784% |
| Fractyl Health, Inc. Common Stock | 401.27 Million USD | 7.83% |
| Rani Therapeutics Holdings, Inc. | 32.47 Million USD | -1038.959% |
| MoonLake Immunotherapeutics | 13.04 Million USD | -2734.327% |
| Palisade Bio, Inc. | 2.73 Million USD | -13403.249% |
| Tourmaline Bio, Inc. | 5.25 Million USD | -6940.815% |
| Beam Therapeutics Inc. | 478.38 Million USD | 22.687% |
| Neurogene Inc. | 36.54 Million USD | -911.94% |
| Mirum Pharmaceuticals, Inc. | 397.95 Million USD | 7.06% |
| AEON Biopharma, Inc. | 159.88 Million USD | -131.319% |
| CARGO Therapeutics, Inc. Common Stock | 47.65 Million USD | -676.189% |
| Sesen Bio, Inc. | 30.98 Million USD | -1093.694% |
| Enliven Therapeutics, Inc. | 25.96 Million USD | -1324.652% |
| Kiora Pharmaceuticals, Inc. | 7.6 Million USD | -4765.081% |
| Iovance Biotherapeutics, Inc. | 195.73 Million USD | -88.954% |
| Taysha Gene Therapies, Inc. | 192.05 Million USD | -92.575% |
| Athira Pharma, Inc. | 30.05 Million USD | -1130.509% |
| Vaccinex, Inc. | 5.94 Million USD | -6124.403% |
| HCW Biologics Inc. | 15.05 Million USD | -2357.184% |
| XOMA Corporation | 145.58 Million USD | -154.056% |
| Nektar Therapeutics | 267.04 Million USD | -38.498% |
| Arvinas, Inc. | 644.6 Million USD | 42.623% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -1985.667% |
| Merus N.V. | 102.15 Million USD | -262.066% |
| Omega Therapeutics, Inc. | 146.35 Million USD | -152.719% |
| Quince Therapeutics, Inc. | 95.12 Million USD | -288.829% |
| Rezolute, Inc. | 11.73 Million USD | -3051.986% |
| Clene Inc. | 38.95 Million USD | -849.537% |
| Indaptus Therapeutics, Inc. | 2.84 Million USD | -12889.274% |
| BeyondSpring Inc. | 48.26 Million USD | -666.235% |
| Synlogic, Inc. | 32.89 Million USD | -1024.347% |
| Allarity Therapeutics, Inc. | 14.61 Million USD | -2430.993% |
| Phio Pharmaceuticals Corp. | 1.63 Million USD | -22534.884% |
| Peak Bio, Inc. | 20.75 Million USD | -1682.14% |
| Werewolf Therapeutics, Inc. | 63.45 Million USD | -482.824% |
| Krystal Biotech, Inc. | 39.71 Million USD | -831.294% |
| Karyopharm Therapeutics Inc. | 376.64 Million USD | 1.803% |
| SpringWorks Therapeutics, Inc. | 99.56 Million USD | -271.455% |
| Lipella Pharmaceuticals Inc. | 432.72 Thousand USD | -85370.714% |
| MannKind Corporation | 721.36 Million USD | 48.729% |
| Ikena Oncology, Inc. | 22.33 Million USD | -1555.939% |
| Cyclerion Therapeutics, Inc. | 2.08 Million USD | -17630.297% |
| Gyre Therapeutics, Inc. | 102.59 Million USD | -260.517% |
| Gossamer Bio, Inc. | 249.14 Million USD | -48.448% |
| CohBar, Inc. | 1.03 Million USD | -35681.773% |
| Cognition Therapeutics, Inc. | 10.68 Million USD | -3360.137% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -1841.695% |
| Legend Biotech Corporation | 589.93 Million USD | 37.306% |
| Mural Oncology plc | 37.92 Million USD | -875.148% |
| Biora Therapeutics, Inc. | 132.63 Million USD | -178.849% |
| PaxMedica, Inc. Common Stock | 2.29 Million USD | -16013.312% |
| Disc Medicine, Inc. | 22.87 Million USD | -1516.848% |
| Champions Oncology, Inc. | 28.03 Million USD | -1219.258% |
| REGENXBIO Inc. | 262.22 Million USD | -41.043% |
| Ensysce Biosciences, Inc. | 3.35 Million USD | -10909.683% |
| Anavex Life Sciences Corp. | 12.53 Million USD | -2850.806% |
| Cellectar Biosciences, Inc. | 13.43 Million USD | -2653.605% |
| Edgewise Therapeutics, Inc. | 21.2 Million USD | -1644.183% |
| Vaxart, Inc. | 34.02 Million USD | -987.007% |
| PharmaCyte Biotech, Inc. | 20.38 Million USD | -1713.964% |
| Aldeyra Therapeutics, Inc. | 28.53 Million USD | -1196.283% |
| Cellectis S.A. | 249.57 Million USD | -48.194% |
| Longeveron Inc. | 5.33 Million USD | -6829.998% |
| Repare Therapeutics Inc. | 41.81 Million USD | -784.416% |
| Sarepta Therapeutics, Inc. | 2.4 Billion USD | 84.623% |
| Inozyme Pharma, Inc. | 60.36 Million USD | -512.666% |
| Revolution Medicines, Inc. | 262.39 Million USD | -40.952% |
| Nymox Pharmaceutical Corporation | 2.1 Million USD | -17453.583% |
| Third Harmonic Bio, Inc. | 8.62 Million USD | -4187.665% |
| ArriVent BioPharma, Inc. Common Stock | 11.8 Million USD | -3034.09% |
| AN2 Therapeutics, Inc. | 14.04 Million USD | -2533.725% |
| Anixa Biosciences, Inc. | 2.15 Million USD | -17094.514% |
| Vertex Pharmaceuticals Incorporated | 5.14 Billion USD | 92.818% |
| Denali Therapeutics Inc. | 122.96 Million USD | -200.785% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -6546.2% |
| Veru Inc. | 32.81 Million USD | -1027.167% |
| Corvus Pharmaceuticals, Inc. | 6.86 Million USD | -5284.394% |
| Cingulate Inc. | 10.36 Million USD | -3469.721% |
| Passage Bio, Inc. | 39.26 Million USD | -842.015% |
| Context Therapeutics Inc. | 4.19 Million USD | -8723.453% |
| Exicure, Inc. | 8.54 Million USD | -4226.284% |
| Day One Biopharmaceuticals, Inc. | 29.5 Million USD | -1153.402% |
| Oramed Pharmaceuticals Inc. | 10.48 Million USD | -3427.122% |
| Scinai Immunotherapeutics Ltd. | 22.04 Million USD | -1578.027% |
| Rhythm Pharmaceuticals, Inc. | 162.98 Million USD | -126.924% |
| Nuvalent, Inc. | 31.82 Million USD | -1062.222% |
| ABVC BioPharma, Inc. | 6.36 Million USD | -5713.827% |
| Carisma Therapeutics, Inc. | 63.02 Million USD | -486.865% |
| Unicycive Therapeutics, Inc. | 18 Million USD | -1954.744% |
| OmniAb, Inc. | 87.4 Million USD | -323.174% |
| Anew Medical, Inc. | 8.24 Million USD | -4387.54% |
| Fennec Pharmaceuticals Inc. | 38.28 Million USD | -865.951% |
| Lipocine Inc. | 2.63 Million USD | -13954.185% |
| Lexeo Therapeutics, Inc. Common Stock | 26.27 Million USD | -1307.788% |
| Nautilus Biotechnology, Inc. | 40.21 Million USD | -819.76% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -1288.246% |
| G1 Therapeutics, Inc. | 86.15 Million USD | -329.294% |
| Bellerophon Therapeutics, Inc. | 5.4 Million USD | -6747.88% |
| Sage Therapeutics, Inc. | 82.74 Million USD | -346.97% |
| Ocugen, Inc. | 23.98 Million USD | -1442.151% |
| Mind Medicine (MindMed) Inc. | 46.4 Million USD | -696.979% |
| Q32 Bio Inc. | 233.12 Million USD | -58.648% |
| Brainstorm Cell Therapeutics Inc. | 9.06 Million USD | -3979.572% |
| Alumis Inc. Common Stock | 53.5 Million USD | -591.29% |
| Equillium, Inc. | 27.95 Million USD | -1222.939% |
| Kyverna Therapeutics, Inc. | 206.59 Million USD | -79.026% |
| Coya Therapeutics, Inc. | 5.62 Million USD | -6473.237% |
| CNS Pharmaceuticals, Inc. | 6.13 Million USD | -5930.587% |
| Galera Therapeutics, Inc. | 157.32 Million USD | -135.088% |
| Evelo Biosciences, Inc. | 69.43 Million USD | -432.678% |
| Comera Life Sciences Holdings, Inc. | 9.97 Million USD | -3608.107% |
| Dominari Holdings Inc. | 4.63 Million USD | -7879.59% |
| Edesa Biotech, Inc. | 1.84 Million USD | -19982.894% |
| vTv Therapeutics Inc. | 29.56 Million USD | -1150.901% |
| Bio-Techne Corporation | 744.34 Million USD | 50.311% |
| Agios Pharmaceuticals, Inc. | 126.09 Million USD | -193.304% |
| Harmony Biosciences Holdings, Inc. | 344.45 Million USD | -7.373% |
| Prelude Therapeutics Incorporated | 40.57 Million USD | -811.532% |
| Candel Therapeutics, Inc. | 28.95 Million USD | -1177.252% |
| iTeos Therapeutics, Inc. | 92.36 Million USD | -300.448% |
| Nkarta, Inc. | 105.6 Million USD | -250.241% |
| BioCardia, Inc. | 4.59 Million USD | -7957.821% |
| Iterum Therapeutics plc | 32.66 Million USD | -1032.368% |